Abstract

Field effect transistor (FET) biosensors provide highly sensitive and rapid detection of bioactive proteins and biomarkers. However, the interface scattering may degrade device performance and the supported substrate also limits the exposed area to biological analytes. Here, a suspended heterostructure field effect transistor (FET) was fabricated for the detection of prostate specific antigen (PSA) in clinical serum samples from patients with prostate cancer. First, we tested the performance of the biosensor by β-actin detection, and the suspended CNTs/MoS2 heterostructure FET showed higher mobility, conductivity and sensitivity with enhanced stability compared to the conventional supported MoS2 FET. Furthermore, the suspended device showed ultrasensitive detection of PSA with the limit of detection (LOD) as low as 10-13 μg/μL and large detection range from 10-13 to 10-4 μg/μL. The device also showed rapid response and higher stability. For clinical application, multiple serum samples were analyzed by the suspended CNTs/MoS2 FET biosensors. The PSA concentration measured by the device was highly consistent with those obtained by the enzyme-linked immunosorbent assays (ELISA) method. Taken together, the suspended CNTs/MoS2 FET showed sensitive and reliable detection capability with great potential for rapid clinical examination and biomarker monitoring.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call